Open Label Study of BOTOX® (Botulinum Toxin Type A) as Headache Prophylaxis in Chinese Patients With Chronic Migraine

Summary

This study is an open-label extension study to evaluate the safety, tolerability and efficacy of BOTOX® as headache prophylaxis in Chinese patients with chronic migraine who have successfully completed the double-blind study: 1313-301-008.

Timeline

Start

2018-01-15

Primary completion

2021-09-09

Completion

2021-09-09

Outcome

Outcome not reported

Stopped: “Corporate Decision”

Drugs

Indications